__NUXT_JSONP__("/drugs/Indibulin", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"204205-90-3",chebiId:"",chemicalFormula:"C22H16ClN3O2",definition:"A synthetic small molecule with antimitotic and potential antineoplastic activities. Indibulin binds to a site on tubulin that is different from taxane- or Vinca alkaloid-binding sites, destabilizing tubulin polymerization and inducing tumor cell cycle arrest and apoptosis. This agent has been shown to be active against multidrug-resistant (MDR) and taxane- resistant tumor cell lines.",fdaUniiCode:"80K4H2RB8P",identifier:"C2049",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C25974"],synonyms:["D 24851","D-24851","INDIBULIN",a,"N-(Pyridin-4-yl)-(1-(4-chlorobenzyl)indol-3-yl)glycoxylamide","ZIO-301"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FIndibulin",extension:".json",createdAt:b,updatedAt:b}}],fetch:{},mutations:void 0}}("Indibulin","2021-10-30T13:37:17.783Z")));